| abstract |
The present invention relates to at least one new human GLP-1 mimetic antibody, or a specific part or variant thereof, including isolated nucleic acids that encode at least one GLP-1 mimetic antibody, or a specific part or variant thereof; GLP-1 mimetic antibody, or a specific part thereof, or variants, vectors, host cells, transgenic animals or plants, and methods for their preparation and use, including therapeutic compositions, methods and devices. |